SEC Form 5 · accession 0000899243-17-004037
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James N Wilson
Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 16, 2016 | G | 112,000 | $9.46 | D | 789,067 | I | James N. Wilson and Pamela D. Wilson Trust |
Table II — derivative securities
No Table II lines on this filing.